144 related articles for article (PubMed ID: 21682816)
21. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
Kumagai R; Ichimiya Y
Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
[No Abstract] [Full Text] [Related]
22. [Delusions of parasitosis: An up-to-date review].
Freudenmann RW
Fortschr Neurol Psychiatr; 2002 Oct; 70(10):531-41. PubMed ID: 12376915
[TBL] [Abstract][Full Text] [Related]
23. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
Nurowska K; Welbel L
Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
[No Abstract] [Full Text] [Related]
25. Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia.
Mizuki Y; Takaki M
J Clin Psychopharmacol; 2015 Feb; 35(1):101-2. PubMed ID: 25502488
[No Abstract] [Full Text] [Related]
26. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
Stahl SM; Shayegan DK
J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
[TBL] [Abstract][Full Text] [Related]
27. Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.
Pehlivanidis A; Spyropoulou AC; Tourkantonis A; Papadimitriou GN
Clin Neuropharmacol; 2010 May; 33(3):168. PubMed ID: 20502137
[No Abstract] [Full Text] [Related]
28. Maintaining symptom control: review of ziprasidone long-term efficacy data.
Schooler NR
J Clin Psychiatry; 2003; 64 Suppl 19():26-32. PubMed ID: 14728087
[TBL] [Abstract][Full Text] [Related]
29. Risperidone: an analysis of the first three years in general use.
Gutierrez-Esteinou R; Grebb JA
Int Clin Psychopharmacol; 1997 Sep; 12 Suppl 4():S3-10. PubMed ID: 9352340
[TBL] [Abstract][Full Text] [Related]
30. Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin.
Suzuki Y; Tsuneyama N; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
Psychiatry Clin Neurosci; 2012 Jun; 66(4):370-1. PubMed ID: 22624745
[No Abstract] [Full Text] [Related]
31. Alterations of dopamine and serotonin transmission in schizophrenia.
Remington G
Prog Brain Res; 2008; 172():117-40. PubMed ID: 18772030
[TBL] [Abstract][Full Text] [Related]
32. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
33. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
Villeneuve A; Dogan K; Lachance R; Drolet A
Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
[No Abstract] [Full Text] [Related]
34. Efficacy of risperidone on positive features of schizophrenia.
McEvoy JP
J Clin Psychiatry; 1994 May; 55 Suppl():18-21. PubMed ID: 7520904
[TBL] [Abstract][Full Text] [Related]
35. Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?
Osimo EF; Goujon MJ; Perez J; Murray GK
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936353
[TBL] [Abstract][Full Text] [Related]
36. [Risperidon--contribution to an integrated therapy of schizophrenia. Yearly session of the German Society for Psychiatry, Psychotherapy and Neurology. Düsseldorf, 17 September 1996].
Fortschr Neurol Psychiatr; 1996 Dec; 64(12 Suppl):1-4. PubMed ID: 9131062
[No Abstract] [Full Text] [Related]
37. Early improvement as a predictor of response to blonanserin transdermal patch in patients with schizophrenia.
Kishi T; Nakamura H; Matsuura A; Iwata N
Schizophr Res; 2022 Feb; 240():231-232. PubMed ID: 35091305
[No Abstract] [Full Text] [Related]
38. Atypical neuroleptics in children and adolescents.
Scahill L; Lynch KA
J Child Adolesc Psychiatr Nurs; 1998; 11(1):38-43. PubMed ID: 9611543
[No Abstract] [Full Text] [Related]
39. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.
Kuwilsky A; Krumm B; Englisch S; Dressing H; Zink M
Pharmacopsychiatry; 2010 Aug; 43(6):216-20. PubMed ID: 20589598
[TBL] [Abstract][Full Text] [Related]
40. [Interpretations of hallucinations resolution by patient with chronic schizophrenia--case report].
Murawiec S; Krzystoszek B
Psychiatr Pol; 2009; 43(2):203-12. PubMed ID: 19697790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
